Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) - September 2015.

@article{Albaladjo2017ManagementOD,
  title={Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) - September 2015.},
  author={Pierre Albalad{\'e}jo and Fanny Bonhomme and Normand C Blais and J. P. Collet and David Faraoni and Pierre Fontana and Anne Godi{\'e}r and Juan Vicente Llau and Dan Longrois and Emmanuel Marret and Patrick Mismetti and Nadia Rosencher and St{\'e}phanie Roullet and C Meyer Samama and J F Schved and Pi{\`e}rre Si{\'e} and Annick Steib and Sophie Susen},
  journal={Anaesthesia, critical care & pain medicine},
  year={2017},
  volume={36 1},
  pages={
          73-76
        }
}
Since 2011, data on patients exposed to direct oral anticoagulants (DOAs) while undergoing invasive procedures have accumulated. At the same time, an increased hemorrhagic risk during perioperative bridging anticoagulation without thrombotic risk reduction has been demonstrated. This has led the GIHP to update their guidelines published in 2011. For scheduled procedures at low bleeding risk, it is suggested that patients interrupt DOAs the night before irrespective of type of drug and to resume… CONTINUE READING